Graft-versus-host driven graft-versus-leukemia effect of minor histocompatibility antigen HA-1 in chronic myeloid leukemia patients

被引：20
|
作者：
Mutis, T. [1 ,2 ]
Brand, R. [3 ]
Gallardo, D. [4 ]
van Biezen, A. [3 ]
Niederwieser, D. [5 ]
Goulmy, E. [1 ]
机构：
[1] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands
[2] Univ Med Ctr Utrecht, Dept Clin Chem & Hematol, Utrecht, Netherlands
[3] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands
[4] Hosp Josep Trueta, Inst Catala Oncol, Dept Hematol, Girona, Spain
[5] Univ Leipzig, Dept Hematol, Leipzig, Germany
来源：
LEUKEMIA | 2010年 / 24卷 / 07期
关键词：
STEM-CELL TRANSPLANTATION; CYTOTOXIC T-LYMPHOCYTES; DISEASE; CANCER; GVHD; IMMUNOTHERAPY; MELANOMA; SURVIVAL; COMPLEX; TARGETS;
D O I：
10.1038/leu.2010.115
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1388 / 1392
页数：6
相关论文
共 50 条
  • [21] NIH-defined graft-versus-host disease and evidence for a potent graft-versus-leukemia effect in patients with acute lymphoblastic leukemia
    Terwey, T. H.
    Le Duc, T. M.
    Hemmati, P. G.
    le Coutre, P.
    Nagy, M.
    Martus, P.
    Doerken, B.
    Arnold, R.
    ANNALS OF ONCOLOGY, 2013, 24 (05) : 1363 - 1370
  • [22] Graft-versus-host disease and graft-versus-leukemia after donor leukocyte infusion
    Porter, D
    Levine, JE
    SEMINARS IN HEMATOLOGY, 2006, 43 (01) : 53 - 61
  • [23] Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity
    Stenger, Elizabeth O.
    Turnquist, Heth R.
    Mapara, Markus Y.
    Thomson, Angus W.
    BLOOD, 2012, 119 (22) : 5088 - 5103
  • [24] β2 integrins separate graft-versus-host disease and graft-versus-leukemia effects
    Liang, Yaming
    Liu, Chen
    Djeu, Julie Y.
    Zhong, Bin
    Peters, Thorsten
    Scharffetter-Kochanek, Karin
    Anasetti, Claudio
    Yu, Xue-Zhong
    BLOOD, 2008, 111 (02) : 954 - 962
  • [25] Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?
    Sprangers, Ben
    Fevery, Sabine
    Van Wijmeersch, Bart
    De Somer, Lien
    Waer, Mark
    Billiau, An D.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 4568 - 4594
  • [26] Donor T-cells for hematopoietic-restricted minor histocompatibility antigens are induced in patients with combined Graft-versus-Leukemia and Graft-versus-Host disease
    Pont, M. J.
    van Bergen, C. A. M.
    Honders, M. W.
    van Luxemburg-Heijs, S. A. P.
    Kester, M. G. D.
    Falkenburg, J. H. F.
    Griffioen, M.
    HUMAN GENE THERAPY, 2014, 25 (11) : A40 - A40
  • [27] Graft-versus-host disease and graft-versus-leukemia effect in mice grafted with peripheral newborn blood
    De la Selle, V
    Gluckman, E
    Bruley-Rosset, M
    BLOOD, 1998, 92 (10) : 3968 - 3975
  • [28] Minor histocompatibility antigen HA-1-specific T-cells and graft-versus-leukemia activity following DLI
    Kircher, B
    Wolf, M
    Stevanovic, S
    Rammensee, HG
    Grubeck-Loebenstein, B
    Gastl, G
    Nachbaur, D
    BONE MARROW TRANSPLANTATION, 2003, 31 : S121 - S122
  • [29] MINOR-HISTOCOMPATIBILITY-ANTIGEN UTY AS TARGET FOR GRAFT-VERSUS-LEUKEMIA AND GRAFT-VERSUS-HAEMATOPOIESIS IN THE CANINE-MODEL
    Bund, D.
    Goekmen, F.
    Zorn, J.
    Buhmann, R.
    Kolb, H-J
    Schmetzer, H.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S149 - S150
  • [30] Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft
    Laurin, David
    Hannani, Dalil
    Pernollet, Martine
    Moine, Agnes
    Plumas, Joel
    Bensa, Jean-Claude
    Cahn, Jean-Yves
    Garban, Frederic
    TRANSFUSION, 2010, 50 (02) : 418 - 428
12345